Latest scientific publications

  • Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

  • Auteurs Pellegrino F, de Angelis M, Scilipoti P, Longoni M, Subiela JD, Contieri R, Afferi L, Zamboni S, Suardi N, Musi G, Luzzago S, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Fallara G, Roupret M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Matsumoto S, Fujii Y, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguie M, Bajeot AS, Resca S, Beatrici E, Lambert E, Mottrie A, Mir MC, Umari P, Teoh J, Wong C, Mertens LS, Pichler R, Mori K, Ślusarczyk A, Poyet C, Albisinni S, Aziz A, Volpe A, Shariat S, Pradere B, Karakiewicz P, Necchi A, Ferro M, Montorsi F, Briganti A, Moschini M
  • Revue BJU Int
  • Date de publication 2025-10
Temporal trends and clinical determinants of urinary diversion after radical cystectomy.
  • Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.

  • Auteurs Bergiers I, Köse MC, Skerget S, Malfait M, Fourneau N, Ellis JC, Vanhoof G, Smets T, Verbist B, De Maeyer D, Van Houdt J, Van der Borght K, Verona R, Heidrich B, Kurth W, Delforge M, Meuleman N, Van Droogenbroeck J, Vlummens P, Heuck CJ, Beguin Y, Bahlis N, Casneuf T, Caers J
  • Revue PLoS Genet
  • Date de publication 2025-10
Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.
  • Evolving paradigms in pulmonary hypertension: Highlights of the 6th French Pulmonary Hypertension Network Meeting.

  • Auteurs Boucly A, Beauvais A, Lacoste-Palasset T, Jevnikar M, Riou M, Solinas S, Antigny F, Bauer F, Bertoletti L, Bonnet D, Chaouat A, Cottin V, D'Alto M, Delcroix M, Dewavrin MG, Guignabert C, Hascoet S, Kiely DG, Jaïs X, Jutant EM, Lamblin N, Mercier O, Moceri P, Noel-Savina E, Picard F, Trembath R, Tromeur C, Vachiery JL, Savale L, Humbert M, Sitbon O, Montani D
  • Revue Respir Med Res
  • Date de publication 2025-10
Evolving paradigms in pulmonary hypertension: Highlights of the 6th French Pulmonary Hypertension Network Meeting.
  • EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer.

  • Auteurs Menis J, Greiller L, Demontrond P, Monnet I, Novello S, Livi L, Young R, Decroisette C, Cloarec N, Robinet G, Schott R, Fayette J, Banna GL, De Marinis F, Califano R, Duchemann B, Luciani A, Colantonio I, Fournier B, Pretzenbacher Y, Caramella C, Silva M, Berghmans T, Dingemans AM, Bironzo P, Tugwood J, Zhou C, Hill S, Bradbury K, Morris K, Kilgour E, Dive C, Blackhall F, Besse B
  • Revue Eur J Cancer
  • Date de publication 2025-10
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer.
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Erasme hospital

Erasme Hospital

View all of Erasme's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital